000 | 00945 a2200301 4500 | ||
---|---|---|---|
005 | 20250518034725.0 | ||
264 | 0 | _c20191128 | |
008 | 201911s 0 0 eng d | ||
022 | _a1759-4782 | ||
024 | 7 |
_a10.1038/s41571-019-0215-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBradley, Conor A | |
245 | 0 | 0 |
_aPerioperative FLOT superior to ECF/X. _h[electronic resource] |
260 |
_bNature reviews. Clinical oncology _c08 2019 |
||
300 |
_a465 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aAdenocarcinoma |
650 | 0 | 4 | _aCapecitabine |
650 | 0 | 4 | _aCisplatin |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 | _aEpirubicin |
650 | 0 | 4 | _aFluorouracil |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeucovorin |
650 | 0 | 4 | _aOxaliplatin |
773 | 0 |
_tNature reviews. Clinical oncology _gvol. 16 _gno. 8 _gp. 465 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41571-019-0215-3 _zAvailable from publisher's website |
999 |
_c29622173 _d29622173 |